Anna-Maria Georgoudaki
Anna-Maria Georgoudaki
Karolinska Institutet
nova.edu üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Reprogramming tumor-associated macrophages by antibody targeting inhibits cancer progression and metastasis
AM Georgoudaki, KE Prokopec, VF Boura, E Hellqvist, S Sohn, J Östling, ...
Cell reports 15 (9), 2000-2011, 2016
2432016
TGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis
MF Pang, AM Georgoudaki, L Lambut, J Johansson, V Tabor, K Hagikura, ...
Oncogene 35 (6), 748-760, 2016
1972016
Synergistic induction of adaptive antitumor immunity by codelivery of antigen with α-galactosylceramide on exosomes
U Gehrmann, S Hiltbrunner, AM Georgoudaki, MC Karlsson, TI Näslund, ...
Cancer research 73 (13), 3865-3876, 2013
932013
Heterogeneous expression of the adhesion receptor CD226 on murine NK and T cells and its function in NK‐mediated killing of immature dendritic cells
S Seth, AM Georgoudaki, BJ Chambers, Q Qiu, E Kremmer, MK Maier, ...
Journal of leukocyte biology 86 (1), 91-101, 2009
542009
BAFF-secreting neutrophils drive plasma cell responses during emergency granulopoiesis
R Parsa, H Lund, AM Georgoudaki, XM Zhang, A Ortlieb Guerreiro-Cacais, ...
Journal of Experimental Medicine 213 (8), 1537-1553, 2016
402016
AIRE expressing marginal zone dendritic cells balances adaptive immunity and T-follicular helper cell recruitment
E Lindmark, Y Chen, AM Georgoudaki, D Dudziak, E Lindh, WC Adams, ...
Journal of autoimmunity 42, 62-70, 2013
232013
Successive crystal structure snapshots suggest the basis for MHC class I peptide loading and editing by tapasin
I Hafstrand, EC Sayitoglu, A Apavaloaei, BJ Josey, R Sun, X Han, ...
Proceedings of the National Academy of Sciences 116 (11), 5055-5060, 2019
142019
CD244 is expressed on dendritic cells and regulates their functions
AM Georgoudaki, S Khodabandeh, S Puiac, CM Persson, MK Larsson, ...
Immunology and cell biology 93 (6), 581-590, 2015
132015
Engineering antigen‐specific NK cell lines against the melanoma‐associated antigen tyrosinase via TCR gene transfer
A Parlar, EC Sayitoglu, D Ozkazanc, AM Georgoudaki, C Pamukcu, ...
European journal of immunology 49 (8), 1278-1290, 2019
92019
Sensitivity of dendritic cells to NK‐mediated lysis depends on the inflammatory environment and is modulated by CD54/CD226‐driven interactions
LE Smith, MA Olszewski, AM Georgoudaki, AK Wagner, T Hägglöf, ...
Journal of leukocyte biology 100 (4), 781-789, 2016
82016
Cutting edge: Marginal zone macrophages regulate antigen transport by B cells to the follicle in the spleen via CD21
KE Prokopec, AM Georgoudaki, S Sohn, F Wermeling, H Grönlund, ...
The Journal of Immunology 197 (6), 2063-2068, 2016
82016
Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D
EC Sayitoglu, AM Georgoudaki, M Chrobok, D Ozkazanc, BJ Josey, M Arif, ...
Frontiers in Immunology 11, 40, 2020
52020
Suicide gene therapy for graft-versus-host disease
AM Georgoudaki, T Sutlu, E Alici
Immunotherapy 2 (4), 521-537, 2010
42010
Engineering antigen-specific natural killer cells against the melanoma-associated antigen tyrosinase via TCR gene transfer.
A Parlar, EC Sayitoglu, C Pamukcu, AM Georgoudaki, D Ozkazanc, ...
CANCER IMMUNOLOGY RESEARCH 8 (4), 49-50, 2020
2020
Natural killer cells genetically modified to overexpress DNAM-1 exert enhanced antitumor responses against CD112/CD155+ sarcomas and other malignancies.
EC Sayitoglu, M Chrobok, AM Georgoudaki, BJ Josey, M Hartman, ...
CANCER IMMUNOLOGY RESEARCH 8 (4), 64-65, 2020
2020
Identification of prevalent targets for the development of tailored sarcoma immunotherapies using a rapid clinic-to-bench immunoprofiling pipeline.
AM Georgoudaki, R Krueger, M Hartman, T Chinn, D Tran, R Potens, ...
CANCER IMMUNOLOGY RESEARCH 8 (4), 50-51, 2020
2020
Abstract A21: Engineering antigen-specific natural killer cells against the melanoma-associated antigen tyrosinase via TCR gene transfer
A Parlar, EC Sayitoglu, C Pamukcu, AM Georgoudaki, D Ozkazanc, ...
Cancer Immunology Research 8 (4 Supplement), A21-A21, 2020
2020
Abstract A23: Identification of prevalent targets for the development of tailored sarcoma immunotherapies using a rapid clinic-to-bench immunoprofiling pipeline
AM Georgoudaki, R Krueger, M Hartman, T Chinn, D Tran, R Potens, ...
Cancer Immunology Research 8 (4 Supplement), A23-A23, 2020
2020
Abstract A55: Natural killer cells genetically modified to overexpress DNAM-1 exert enhanced antitumor responses against CD112/CD155+ sarcomas and other malignancies
EC Sayitoglu, M Chrobok, AM Georgoudaki, BJ Josey, M Hartman, ...
Cancer Immunology Research 8 (4 Supplement), A55-A55, 2020
2020
Exploring immunotherapeutic targets in the tumor microenvironment
AM Georgoudaki
Inst för mikrobiologi, tumör-och cellbiologi/Dept of Microbiology, Tumor and …, 2015
2015
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20